Q2 2026 earnings call recap: deposit surge, NIM ~3.50%, loan/deposit outlook, efficiency & 1% ROA targets—read now.
This article is structured around core categories of AI harms—bias and discrimination, privacy harms, safety failures, lack of transparency, misinformation and broader societal impacts—and then ...
Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload July 24, 2026 9:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results